CEO Corner articles are written by presidents or CEOs of biopharmaceutical or medical device companies that create a drug or device. These articles discuss global industry trends, experiences, and challenges that biopharma CEOs and presidents can relate to and should be aware of. To submit a CEO Corner article, please follow these guidelines.
What The Sale Of Agios’ Oncology Pipeline Taught Me
Anytime a company undergoes organizational change — even if it’s a good change — the road there is not necessarily an easy one. I’d like to share a few things that might make it — or any major decision — easier for you
How European Biopharmas Can Benefit From Establishing A U.S. Presence
The maturity and scale of the biotech industry in the U.S. can offer several competitive advantages, making expansion into the U.S. well worth considering for leaders of biopharma companies formed in other countries, such as across Europe.
Against All Odds: Advancing From R&D To Phase 3
There is nothing more rewarding than knowing that we can help save a life and give hope to patients and their friends and families. Because lives are at stake, there must be more regulations and processes to ensure safety and efficacy.
Capitalization, Coaching, And Clarity Are Keys To Success
Throughout my career, I have employed the following guiding principles to advance treatment options for patients: capitalization is king, hire the right people, and be decisive and humble.
From Academia to Industry – How Biopharma Entrepreneurship Became A Calling
While I knew that I wanted to dedicate my life to developing gene therapies to cure human diseases, I could not have predicted that I would leave academia to become an entrepreneur.
A Black CEO’s Advice To The Next Generation
As one of the few African American CEOs in corporate America, I am in a unique position to share my experience with the next generation of leaders as we continue to face major challenges around inequity, intolerance, and community cohesion.
Coworking Lab Spaces Help Life Science Startups Succeed
While business incubators are not uncommon, facilities like these provide laboratory equipment and staff to manage safety, training, and other lab operations for entrepreneurs to reduce their initial investment expenses.
What I Learned As A Teacher That Made Me A Better Leader
Before I started my career in the pharmaceutical industry, I was a chemistry and biology teacher. While my days in the classroom now feel like a lifetime ago, a day rarely passes that I don't draw upon the range of skills I honed back then.
Never Let Success Go To Your Head — Or Failure Get To Your Heart
We all know most biotech ventures end in failure, but this does not make it any easier when you experience one, especially as a CEO.
How Small Patient Advocacy Groups Can Help Advance Drug Development
Working with large disease societies/organizations can streamline industry efforts to engage with specific patient groups, which can be especially beneficial when developing therapies in larger indications.
BEYOND THE PRINTED PAGE
Did You Expect It Would Take This Long To Go Public?7/19/2021
Laura Niklason, M.D., Ph.D., cofounder and CEO of Humacyte, explains some of the science of her regenerative medicines company so to be public via a SPAC.
Have You Heard Of Eric Dube?6/17/2021
A primer on what makes Eric Dube, Ph.D., CEO of Travere Therapeutics and upcoming feature in Life Science Leader, so inspirational.
How We Have Changed For The Better Thanks To COVID-195/17/2021
An interview with Mei Mei Hu, cofounder and CEO of Vaxxinity, provides an example of how COVID-19 and Zoom have enabled the seeing and showing of one another’s humanness.
LIFE SCIENCE LEADER BLOGS
Recent events of female athletes expressing the need to focus on their mental health seems to point toward mental wellness being one of the next big things, along with women leaders being willing to "rewrite the rules."
Disruption of life routines by COVID-19 provide a CNS opportunity on multiple fronts.